Investigation of the Automatic Technology on the Naída M Hearing Devices
NCT ID: NCT04610216
Last Updated: 2024-05-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
12 participants
OBSERVATIONAL
2020-10-20
2021-09-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Furthermore, a within-subject comparison decreases the variance in the results allowing for fewer subjects when the population using the investigational device is not large in general.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of the Naída CI M90 Sound Processor in Various Acoustic Scenarios
NCT04815343
MeasurIng and Restoring Auditory Awareness for Cochlear Implant Listeners in noisE
NCT06420921
Evaluation of a Binaural Spatialization Method for Hearing Aids
NCT02693704
Evaluation of Frequency Lowering Technique
NCT02303210
Lab Evaluation of Novel Hearing Aid Coupling Method
NCT05377359
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bilateral users: two implant systems
For bilateral CI users two Naida CI M sound processors (one per ear) will be used during the study.
Naida CI M hearing device
speech intelligibility measurement with Naida CI M hearing device
Bimodal users: hearing aid contralateral
For bimodal subjects there will be one Naida CI M sound processor on the implanted ear as well as one hearing aid on the contralateral ear.
Naida CI M hearing device
speech intelligibility measurement with Naida CI M hearing device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Naida CI M hearing device
speech intelligibility measurement with Naida CI M hearing device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Minimum of 18 years of age
* Minimum of six months experience with their implant system
* Minimum of six months experience with the Naída CI Q-Series sound processor
* Ability to give feedback on sound quality
* Speech reception thresholds of no more than 5 dB SNR \> 10 at the French Matrix test obtained during previous visits in the clinical routine
* Fluent in French language
Exclusion Criteria
* Concurrent participation in other study
* Incapacity for consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Advanced Bionics AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpitaux Universitaires de Genève (HUG)
Geneva, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ABIntl-20-15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.